IAN MORTIMER - PRESIDENT & CEO, Director at Xenon Pharmaceuticals Inc.

Insider Transactions and Holdings

Entity Type: Individual
Role: PRESIDENT & CEO, Director
Issuer Symbol: XENE on Nasdaq
All Insider Reports: All Insider Reports

IAN MORTIMER - trading volume in the past year for Xenon Pharmaceuticals Inc.

	Shares	%	Avg Price	Total $
Buys
Sells	-371,571	100%	$56.23	-$20,894,472
Net	-371,571	-100%		-$20,894,472

Holdings reported by IAN MORTIMER for Xenon Pharmaceuticals Inc.

Security	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Shares	14,731	$885,450	$60.11	10 Mar 2026	Direct
Common Shares	14,300	$640,926	$44.82	09 Mar 2026	By Spouse
Share Option (Right to Buy)	350,000			09 Jan 2026	Direct	Common Shares
Restricted Share Units	65,000			09 Jan 2026	Direct	Common Shares
Performance Share Units	0			09 Mar 2026	Direct	Common Shares
Stock Option	0			09 Mar 2026	Direct	Common Shares
Stock Option (Right to Buy)	0			02 Jan 2026	Direct	Common Shares

Transactions reported by IAN MORTIMER for Xenon Pharmaceuticals Inc.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.